Isomorphic Labs Discusses AI-Driven Drug Disc...

AI is reshaping electricity demand. What does increased demand, and the shape of that demand, mean for the electric grid? Ben Sooter, Director of R&D at EPRI joins the podcast to explain why most of an AI model’s lifetime energy use comes from inference rather than training, and ...  Show more

Alibaba.com president Kuo Zhang discusses how AI agents like Accio are reshaping global trade. He shares insights on automating complex B2B sourcing, compressing weeks of work into minutes, lowering barriers for solo entrepreneurs and SMEs, and what AI-native commerce will mean f ...  Show more

Can AI compress the years long research time of a PhD into seconds? Research scientist Max Jaderberg explores how “AI analogs” simulate real-world lab work with staggering speed and scale, unlocking new insights on protein folding and drug discovery. Drawing on his experience wor ...  Show more

<span data-preserver-spaces="true">Today's guest is Liran Belenzon, Co-founder and CEO of BenchSci. BenchSci is a global leader in AI solutions for preclinical R&D that helps decipher complex biomedical research using proprietary technology. Liran joins us to discuss how AI is ...

Bringing new drugs to market is a costly, time-consuming endeavor. On top of that, most medicines fail at some point in the research and development phase. Sarah Guo is joined by Sajith Wickramasekara, co-founder and CEO of Benchling, a company that has not only become the centra ...  Show more

Can AI compress the yearslong research time of a PhD into seconds? Research scientist Max Jaderberg explores how “AI analogs” simulate real-world lab work with staggering speed and scale, unlocking new insights on protein folding and drug discovery. Drawing on his experience work ...  Show more